MissionIRNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Completes Management Transition Process with Appointment of CEO, President

Sigma Labs (NASDAQ: SGLB), a leading provider of in-process, quality-assurance software for the additive manufacturing industry, recently appointed experienced software industry executive Mark K. Ruport as CEO and president (http://ibn.fm/oNSOj). The move finalizes the company’s management transition process. An article further discussing the new appointment reads, “In his new assignment, Ruport will leverage his experience with public and private software companies to lead Sigma Labs through a period of significant growth and success. ‘The ability to have an immediate, tangible impact on Sigma Labs with the apparent adoption of its incredible technology in the marketplace is a unique and exciting opportunity,’ Ruport said in a news release announcing his December appointment. ‘My focus will be on accelerating our commercial adoption with strategic partners and amplifying the recent success John [Rice] and his team have achieved. This blueprint is something I am very familiar with given my experience with disruptive companies in the software sector, and I look forward to working with the entire team at Sigma Labs to drive forward its strategic initiatives.’”

To view the full article, visit http://ibn.fm/DscFj

About Sigma Labs Inc.

Sigma Labs is a leading provider of quality-assurance software to the commercial 3D-metal-printing industry under the PrintRite3D(R) brand. Sigma is a software company that specializes in the development and commercialization of real-time, computer-aided inspection (“CAI”) solutions known as PrintRite3D for 3D advanced-manufacturing technologies. Sigma Labs’ advanced computer-aided software product revolutionizes commercial additive manufacturing, enabling nondestructive quality assurance mid-production, uniquely allowing errors to be corrected in real time. For more information, please visit www.SigmaLabsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Rebrands Investor Intelligence Platform

SRAX (NASDAQ: SRAX) recently announced the rebranding of its investor intelligence platform from SRAX IR to Sequire. An article further discussing the platform reads, “The investor-relations platform, which enables companies to monitor their shareholders’ buying and selling behavior and carry out virtual investor meetings among other services, announced that it had gained 59 corporate subscribers as of the end of 2019 — a remarkable 64% increase relative to the quarter ending Sept 30, 2019. . . . ‘We are thrilled to announce the new brand, giving the platform its own identity separate from SRAX,’ SRAX CEO and founder Christopher Miglino noted in a news release regarding the rebranding announcement (http://ibn.fm/tfKtt). ‘It’s also arriving at an opportune time as we are developing new intelligent technologies to further provide public companies the tools to reach and engage their shareholders.’”

To view the full article, visit http://ibn.fm/tZU7w

About SRAX

SRAX is a digital-marketing and consumer-data-management technology company. SRAX’s technology unlocks data for brands in the CPG, investor relations, luxury and lifestyle verticals. Through its various platforms, SRAX is monetizing its data sets and growing multiple recurring revenue streams. BIGtoken is a consumer-managed data marketplace where people can own and earn from their data. The platform also provides advertisers and media companies access to transparent, verified consumer data to better reach and serve audiences. Sequire is a premier platform for investor intelligence and communication. Through Sequire, public companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX and its verticals, visit www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Helomics Subsidiary Holds Unique Cancerous Tumor Inventory

Predictive Oncology (NASDAQ: POAI) CEO Dr. Carl Schwartz recently referred to the company’s Helomics subsidiary as a “major asset” during an exclusive NNW interview with Stuart Smith (http://ibn.fm/8knZX). An article discussing the interview reads, “During the interview, Schwartz pointed out that Helomics’ collection of more than 150,000 cancer tumors is the largest inventory of its kind in the world and that the impressive collection ‘was amassed over the last two decades by physicians sending in cancerous tumors to be tested with the known therapies of the time. The results of these tests were in turn sent back to the referring physicians to be used as a guide or a reference as desired for treatment of the evaluated tumor,’ he continued. ‘And the evaluated tumor was placed back in the physician’s therapy inventory. That’s how we amassed all these tumors.’ . . . Schwartz explained that POAI was intent on proving that it can sequence, ‘which is genetically profile our tumors, and do what is called a ‘reach back,’ or examination of what eventually happened to these patients over an extended period of time. I want to strongly emphasize that Helomics is the only company with the ability to do this ‘reach back’ at this time because only we have a patient history.’”

To view the full article, visit http://ibn.fm/ZoNgh

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (domestic, international and other) that contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient-treatment decisions by providing an evidence-based road map for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled with a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform Kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient-specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Secures $2.5 Million in Cash Proceeds from Recent Warrant Exercises

Genprex (NASDAQ: GNPX) today announced the exercise of warrants to purchase approximately 5.4 million shares of common stock issued in connection with capital raises in May 2018 and November 2019 with two institutional investors at a price of $0.46 per share, resulting in its receipt of approximately $2.5 million in cash proceeds. According to the update, the warrants were exercised on or about May 22, 2020, the first day they became exercisable under their respective agreement terms. The exercised warrants represent approximately 70% of the company’s overall outstanding warrants and include all warrants that have been issued to investors in the company’s public financings to date. After the exercise, remaining warrants carry a weighted average exercise price of approximately $3.93. Genprex believes the elimination of the majority of its outstanding warrants represents a significant milestone for the company, providing a dramatically simplified capital structure.

To view the full press release, visit http://ibn.fm/1QWNi

About Genprex, Inc.

Genprex, Inc. is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The Company’s lead product candidate, Oncoprex(TM), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). Oncoprex has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for Oncoprex immunogene therapy for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)). For more information, please visit the company’s website at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Pending Partner Cannaworx to Launch FDA Registered, Hemp-Containing Supplements with Immune Booster Claim

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced that its pending merger partner Cannaworx, Inc. will be launching its patented and proprietary immune booster supplement by mid-July 2020. According to the update, the company believes that post-launch, this product could be one of the very few, and perhaps the only, OTC (over the counter), FDA registered, hemp-containing supplements with an immune booster claim. “To further enhance the immune boosting effect, we added hemp seed oil (no THC) to our patented formulation. Hemp seed oil is rich in essential fatty acids (e.g., omega-6 and omega-3) and antioxidants that may help fight inflammation, cancer, diabetes, and heart disease,” Dr. Bobby Ghalili, co-founder and president of Cannaworx, stated in the news release. “Omega-3 is also thought to have a positive impact on the bowel microbiome as a prebiotic, providing further support to the immune system. The manufacturing process of the patented 44 amino acid fragment formulation is highly proprietary, protected, and would be nearly impossible to imitate.”

To view the full press release, visit http://ibn.fm/nqpvZ

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life-sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure-cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the biopharma contract services sector, and (2) the use of its recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and (ii) prepare higher-quality, homogenized, extended shelf-life or room-temperature, stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Enters Partnership with Sutesen to Expand Smart Immersive Education Classes

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) today announced its entry into a three-year partnership with smart education service provider, Sutesen Information Technology Ltd. (“Sutesen”), to expand Blue Hat’s Smart Immersive Education Classes, or “AR Immersive Classes” (“ARIC”), in Guangxi province, China. According to the update, the partnership aims to commercially launch ARIC in up to 1,000 Guangxi preschools in three years. “We believe the development of AR technology has great potential to change the way children interact with educational content, merging the real with the virtual for a truly immersive smart educational experience,” Blue Hat CEO Xiaodong Chen stated in the news release. “We are excited by the bright prospects of this wide-ranging partnership between Blue Hat and Sutesen, and we look forward to close co-operation in sharing resources such as channels, products, technology and content, as well as joint promotion of AR education.”

To view the full press release, visit http://ibn.fm/k06Fe

About Blue Hat

Blue Hat Interactive Entertainment Technology is a producer, developer and operator of AR interactive entertainment games and toys in China, including interactive educational materials, mobile games and toys with mobile game features. The company’s interactive entertainment platform creates unique user experiences by connecting physical items to mobile devices, which creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. Distinguished by its own proprietary technology, Blue Hat aims to create an engaging, interactive and immersive community for its users. For more information, please visit the company’s investor relations website at www.IR.BlueHatGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://ibn.fm/BHAT

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Implements Changes as Part of Strategic and Operational Review of Business

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced a series of operational changes designed to optimize its organizational structure, streamline operations, and preserve and maximize cash-on-hand. According to the update, the company, as part of its strategic and operational review of the business, is implementing changes including a material reduction in the company’s operating cash outflows; a focus on generating positive cash flow; and a focus on maximizing returns on existing assets. In addition, the company today reaffirmed its intention, under its previously announced normal course issuer bid (the “NCIB”), to repurchase subordinated voting shares in accordance with its NCIB. “We believe that sharpening our focus on financial discipline, operational excellence, and opportunistic capital deployment on our investment pipeline will yield long-term results for shareholders,” Canopy Rivers’ CEO and President Narbe Alexandrian stated in the news release. “In addition, the strategic utilization of our NCIB could be an important tool to provide attractive returns to shareholders.”

To view the full press release, visit http://ibn.fm/KW3bT

About Canopy Rivers

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire portfolio. For more information, visit www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://ibn.fm/CNPOF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Reports Voting Results from Annual Shareholder Meeting

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, on Wednesday reported results from the election of directors and other matters that were voted on at its annual meeting of shareholders, which was held virtually on May 27, 2020. Among other highlights, the company reported that the eight nominees proposed by management for election as directors were successfully elected by the shareholders through a mixture of votes by proxy and electronic poll. Other matters that were approved by the shareholders during the meeting include the appointment of KPMG LLP as the auditors of the company; the compensation of the company’s named executive officers, on a non-binding advisory basis, commonly referred to as a “Say-on-Pay” vote; and, on a non-binding advisory basis, the shareholders selected every three years as the favored rate of holding future non-binding advisory votes on the compensation of the company’s named executive officers. Further details regarding these topics are available in the Management Information Circular of the company dated April 7, 2020.

To view the full press release, visit http://ibn.fm/AsXHL

About Energy Fuels

Energy Fuels is a leading US-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant. Its corporate offices are near Denver, Colorado, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers, the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year, and has the ability to produce vanadium when market conditions warrant. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is currently on standby. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S., and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Targets Massive International Markets

Pressure BioScience (OTCQB: PBIO) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries. On April 29, PBIO announced its entrance into a binding letter of intent to acquire Cannaworx Inc. (http://ibn.fm/TfZgu). An article discussing the company reads, “The merged entity, equipped with an extensive intellectual property portfolio utilizing a proprietary pressure platform, nanotechnology and advanced delivery systems, plans to disrupt a number of major world markets. These include the international cosmetics market, projected to reach $758 billion by 2025 (http://ibn.fm/5N4vZ); the global agricultural technology and products market, projected at $729 billion by 2023 (http://ibn.fm/XLNAf); the global biopharmaceuticals market, expected to reach $389 billion by 2024 (http://ibn.fm/7VJpy); as well as the U.S. hemp-derived CBD market, anticipated to reach $23.7 billion by 2023 (http://ibn.fm/4bLkg). . . . Cannaworx’s diverse portfolio of products and intellectual property was developed by its founders Bobby Ghalili, DMD, and Adrienne Denese, MD, PhD. Ghalili and Denese bring extensive medical expertise and product innovation into the newly combined public company. They have an impressive multiyear track record of developing and selling personal-care and nutrition products.”

To view the full article, visit http://ibn.fm/doJ5a

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life-sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure-cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the biopharma contract services sector, and (2) the use of its recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and (ii) prepare higher-quality, homogenized, extended shelf-life or room-temperature, stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Announces Resounding Success of QiaQia Food, One of the First Companies to Benefit from Integrated Cloud Platform

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that the WeChat mini-program of QiaQia Food Co., Ltd, a client of iClick’s subsidiary Changyi, has achieved impressive growth. According to the update, the mini program leveraged iClick’s integrated enterprise and marketing cloud platform with monthly GMV growth of 180% on average since its launch. “iClick is delighted by the resounding success of QiaQia Food, one of the first companies to benefit from our Integrated Enterprise and Marketing Cloud platform that provides full-stack marketing and consumer lifecycle solutions,” Jian “T.J.” Tang, CEO and co-founder of iClick, stated in the news release. “COVID-19 represents possibly the greatest challenge ever faced by the global retail industry, and retailers are increasingly recognizing the importance of online-offline integration and digitalization through tailored smart retail solutions. QiaQia is just one of the many successful cases we have helped in our first year as we rolled out our integrated solutions business and we remain highly confident in the huge market potential ahead.”

To view the full press release, visit http://ibn.fm/Qvwo3

About iClick Interactive Asia Group Limited

iClick Interactive Asia Group Limited (NASDAQ: ICLK) is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, its proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and is currently operating in ten locations worldwide including Asia and Europe.

For more information, please visit ir.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Energy Fuels Inc.’s (NYSE American: UUUU) (TSX: EFR) Virtual Investor Conference Presentation Available for On-Demand Viewing

Energy Fuels’ (NYSE American: UUUU) (TSX: EFR) presentation for the Australian Mining and Technology Metals Virtual Investor Conference is now available for on-demand viewing. Interested parties are invited to log-on to VirtualInvestorConferences.com to view Energy Fuels’ and other company presentations. According to the update, the presentations will be available for 90 days on a 24-hour-per-day, 7-day-per-week basis. In addition, for the next three weeks, investors, advisors and analysts may download shareholder materials from the “virtual trade booth.”

To view the full press release, visit http://ibn.fm/CeYbL

About Energy Fuels

Energy Fuels is a leading US-based uranium mining company, supplying U3O8 to major nuclear utilities. The Company also produces vanadium from certain of its projects, as market conditions warrant. Its corporate offices are near Denver, Colorado, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers, the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year, and has the ability to produce vanadium when market conditions warrant. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is currently on standby. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S., and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the Company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” For more information, visit the Company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Revised Date for Release of Financial Results for Q4 and Fiscal Year 2020

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced a revised date for the reporting of its financial results for the fourth quarter and fiscal year ended March 31, 2020, now scheduled for release before markets open on Wednesday, June 3, 2020. According to the update, following release of its results, Canopy Rivers will host a conference call and audio webcast with President and CEO Narbé Alexandrian and CFO Eddie Lucarelli at 9:00 a.m. Eastern Time on Wednesday, June 3, 2020. A live audio webcast will be available at http://ibn.fm/DsfK3. Interested parties may join the conference call by dialing 1-888-390-0546 (North America Toll Free) and entering conference ID: 60093937. A replay of the call will be accessible by telephone until 11:59 p.m. Eastern Time on Friday, July 3, 2020, by dialing 1-888-390-0541 (Toll Free) and entering replay password: 093937#.

To view the full press release, visit http://ibn.fm/N6EGY

About Canopy Rivers

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire portfolio. For more information, visit www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://ibn.fm/CNPOF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) CEO Exchanges $2.1M Promissory Note for Common Stock

Predictive Oncology (NASDAQ: POAI) recently entered an agreement with POAI CEO Dr. Carl Schwartz to exchange a $2.1 million promissory note for newly issued equity (http://ibn.fm/lzYPh). An article discussing the company reads, “‘This agreement enables the company to strengthen its balance sheet and simplify its capital structure at a critical juncture in our quest to commercialize our highly valuable database of cancer tumors for the advancement of predictive medicine,’ Schwartz said in a news release. ‘At the same time, it reinforces my commitment and demonstrates my belief in our ability to emerge as a leader in the application of artificial intelligence to oncology therapies.’ . . . According to the agreement, Schwartz will exchange the promissory note for shares of common stock, $0.01 par value of Predictive Oncology at market value. In addition, Schwartz agrees not to sell or otherwise transfer one-half of the shares for three months after the date of the exchange agreement and not to sell or otherwise transfer the remaining shares for six months after the date of the agreement. Negotiated between POAI and Schwartz on an arms-length basis, the agreement was approved by the Audit Committee of the company’s board of directors in accordance with Nasdaq listing requirements.”

To view the full article, visit http://ibn.fm/ZfB9k

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (domestic, international and other) that contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient-treatment decisions by providing an evidence-based road map for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled with a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform Kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient-specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Provides Insight to Company Leaders Operating in Unstable Economies

SRAX (NASDAQ: SRAX) CEO Christopher Miglino recently authored a Forbes article titled “Communicating with Investors and Understanding Their Behavior During a Major Crisis” (http://ibn.fm/cfHOM). An article further discussing the company reads, “‘All in all,’ concluded Miglino, ‘during a major crisis, it’s extremely important to be open, honest and direct with your shareholders. They deserve it. Put yourself in their shoes, and that realization should click pretty quickly. Stay smart and calm, and the rest will follow.’ . . . Miglino is ideally qualified to share insight and suggestions to leaders of publicly held companies. He has spent the past two decades working in the digital advertising space and has successfully launched and sold two companies; both of those companies were sold to publicly traded companies on the NASDAQ. Currently CEO of SRAX, a digital marketing and data-management-technology company, Miglino has extensive experience and understanding of how to lead companies to success and growth.”

To view the full article, visit http://ibn.fm/8AYiI

About SRAX

SRAX is a digital marketing and consumer-data-management technology company. SRAX’s technology unlocks data for brands in the CPG, investor relations, luxury and lifestyle verticals. Through its various platforms, SRAX is monetizing its data sets and growing multiple recurring revenue streams. BIGtoken is a consumer-managed data marketplace where people can own and earn from their data. The platform also provides advertisers and media companies access to transparent, verified consumer data to better reach and serve audiences. Sequire is a premier platform for investor intelligence and communication. Through Sequire, public companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX and its verticals, visit www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – iClick Interactive Asia Group Ltd. (NASDAQ: ICLK) Announces Record Results for Q1 2020

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced unaudited financial results for the first quarter ended March 31, 2020. Among the highlights, the company reported record first quarter revenues, gross profit, adjusted EBITDA and gross billing. In addition, iClick reported its second consecutive quarter of positive adjusted net income. “We are proud of achieving record results in gross billing, revenue, gross profit, adjusted EBITDA and adjusted net income in this quarter compared to any other first quarters in our company’s history despite facing massive challenges due to the coronavirus pandemic,” Jian “T.J.” Tang, CEO and co-founder of iClick, stated in the news release. “We reported revenue of US$49.0 million, an increase of 25% year-over-year, while our gross billing grew to US$158.0 million, an increase of approximately 64% from the first quarter of 2019. With the continued improvement in profitability and cost controls, we recorded gross profit of US$13.3 million, adjusted EBITDA of US$2.4 million and adjusted net income of US$0.6 million.”

To view the full press release, visit http://ibn.fm/FZvJu

About iClick Interactive Asia Group

iClick Interactive Asia Group Limited is an independent, online marketing and enterprise-data-solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, the company’s proprietary platform possesses omni-channel marketing capabilities and fulfills various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and currently operates in 10 locations worldwide, including Asia and Europe. For more information, visit the company’s website at www.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary Helomics Leverages Cutting-Edge Tech and Datasets to Improve Cancer Outcomes

• POAI subsidiary Helomics helps oncologists individualize cancer treatment using patient-derived tumor models to improve outcomes
• Helomics’ tumor genomic and drug response database is one of the largest in the world with over 150,000 tumors across 137 cancer types
• Expected CAGR of 10.3% from 2018-2024 for oncology segment of precision medicine industry

The relationship between a patient and their cancer is personal: it’s specific, and it necessitates personalized treatment to be defeated effectively. Unfortunately, oncologists’ ability to personalize treatment for patients has largely been anything but, often resembling a trial-and-error method. This is largely because we have few targeted treatments or enough actionable data about how tumors with specific mutations respond to drugs. One innovator in the cancer research space, Predictive Oncology Inc. (NASDAQ: POAI), is working to change this dynamic by bringing its cutting-edge, AI-driven predictive models of tumor drug response and outcome to cancer research. These models predict how tumors respond to drugs and can be used for both clinical decision support, i.e. individualizing a patient’s therapy as well as research into new therapies, in partnership with the pharmaceutical and biotech industries.

With a mission to improve the standard of care for cancer patients, Helomics’ TruTumor(TM) platform harnesses the power of the patient’s own living tumor to address challenges oncologists often face when assessing patients and individualizing treatments. The clinically validated (in ovarian cancer) cell-based functional platform is in use today and profiles patient tumors, identifying key biomarkers and how the tumor responds to drugs and helps the oncologist determine a tailored therapy for that patient.

Helomics’ is building AI-driven predictive models by leveraging; a unique database of 150,000 tumor genomic and drug response profiles gathered from over 15 years of clinical testing using its TruTumor platform; access to over 15 years of outcome data from a national network of oncologists; plus a physical biobank of tumor samples that is being sequenced as part of its CancerQuest 2020 initiative (http://ibn.fm/B9mmE) to generate rich genomic profiles.

Along with subsidiaries TumorGenesis and Skyline Medical, POAI brings precision medicine to the treatment of cancer through collaborations with key players in the pharmaceutical, diagnostic and biotech industries. According to Mordor Intelligence Inc, oncology is expected to have the largest share of the precision medicine industry with estimated market dominance in excess of 30% over other precision medicine segments, and a CAGR of 10.3% from 2018 to 2024 (http://ibn.fm/8fqiH).

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (PDx) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug repose to improve outcomes for the patients of today and tomorrow.

For more information, visit the company’s website at www.Predictive-Oncology.com

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

SRAX Inc. (NASDAQ: SRAX) Offers Valuable Consumer Insights in Shifting COVID-19 Era with BIGtoken Data-Driven Platform

• SRAX conducted two surveys using consumer-driven BIGtoken platform
• Mother’s Day study showed 68% of users purchased gifts, 49% bought online
• COVID-related survey reveals 67% of users afraid of early reopening, 32% intend to immediately purchase non-essential services
• BIGtoken platform encompasses 16 million users across more than 30 countries with $400 million potential projected revenue by January 2022

As a global society adapts to COVID-19 restrictions, consumer patterns and preferences continue to shift – and insights into these changes are more sought-after than ever before. Brands across all industries seek to leverage valuable consumer data to increase sales, and companies like SRAX Inc. (NASDAQ: SRAX), a technology company focused on digital marketing and consumer data management, have valuable resources to meet this need. SRAX recently released two studies showing key insights about changing consumer patterns in connection with the COVID-19 panic. Through the use of its BIGtoken platform, SRAX leverages the consumer data of its 16 million users to create valuable data sets that are accessible by marketers for a fee. The company also compensates its users with cash or gift cards when they opt in and give access to their data.

The first BIGtoken study was conducted with Publicis Groupe, one of the largest marketing and communications companies in the world (http://ibn.fm/dd3jV). Using BIGtoken’s Lightning Insights, millions of consumers were surveyed to analyze their buying activities surrounding Mother’s Day, giving insight into how the current economic conditions are affecting consumption patterns. While the results showed that 70% of the study participants felt Mother’s Day was either ‘neutral’ or ‘not important’, 84% still celebrated the day, 68% bought a gift, and 49% made that purchase online.

In addition to the Mother’s Day survey, the BIGtoken platform was also leveraged to research the sentiments of users regarding the reopening of the United States (http://ibn.fm/I8Nq6), revealing that 67% feared it will lead to an increased spread of the coronavirus while 32% intend to immediately purchase non-essential goods and services once the country reopens. According to the survey, the types of businesses that users intend to visit include state parks and beaches (39.7%), supermarkets and banks (37.2%), barber shops and nail salons (33.3%), restaurants (29.5%), and non-essential retail stores (25.6%).

The unprecedented economic landscape created by COVID-19 and the resulting lockdown has prompted many companies to seek unique insights into consumer behavior so they can adapt to the increasingly challenging business environment. Data gleaned from SRAX’s BIGtoken platform provides valuable consumer insights, allowing brands to draw inferences to inform their marketing strategy.

“BIGtoken is happy to play a role in helping brands understand rapidly changing consumer behaviors during this time,” BIGtoken Executive Vice President George Stella stated in a recent news release. “Because our users are compensated as they share their data, we’re proud to put a little money back in their pockets. We look forward to continuing to use our platform to help in this crisis by connecting brands directly with their customers and providing quick, relevant insights and audiences they can activate.”

With over 16 million users across more than 30 countries, SRAX’s BIGtoken platform compensates users in addition to providing brands the ability to target and access specific niche groups across 25,000 unique market segments with the power to submit specialized queries that include location and purchase history. Potential revenue for BIGtoken is projected at $400 million by January 2022, with plans to formally launch into several international markets that include Europe, India and Mexico.

Along with BIGtoken, SRAX also unlocks data for the finance space through Sequire – its premier platform for investor intelligence and communication that allows public companies to track investor behaviors and trends for use in engaging current and potential investors.

With an aim to deliver the tools to unlock the value of data, SRAX’s technology helps brands gain insights across marketing channels in the consumer goods, investor relations, luxury, and lifestyle verticals.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Providing COVID-19 Antibody Testing for Commercial Property Firm in Atlanta

Trxade Group (NASDAQ: MEDS) and its wholly owned subsidiary, Integra Pharma Solutions, were recently featured in a CoStar.com article titled ‘Lee & Associates Atlanta to Reopen Office Monday, Offer Coronavirus Antibody Testing’. The article reports that commercial property firm Lee & Associates Atlanta will be one of the first Atlanta-based firms to reopen. The firm is working with Saidcard and Integra Pharma Solutions to ensure its employees will be tested for the COVID-19 antibodies. These antibodies “show if you had a previous infection with the virus,” according to the Centers for Disease Control and Prevention (“CDC”). The CDC also stated that it is unclear if the antibodies provide immunity from getting infected again. “We are working to ensure that all of the test kits we are providing our customers through Integra Pharma are sourced from manufacturers that have submitted an emergency use authorization with the [Food & Drug Administration],” Saidcard Chief Operating Officer Jo Ram said in a statement. “Additionally, as we roll this offering out to our customers, if a person tests positive for antibodies, we follow it up with a PCR test to see if they currently have the virus and need to be quarantined, or are virus free and can go back to work.”

To view the full article, visit http://ibn.fm/VoD6G

About Trxade Group Inc.

Headquartered in Tampa, Florida, Trxade Group is an integrated drug-procurement, delivery and healthcare platform that enables price transparency and increased profit margins to buyers and sellers of pharmaceuticals, makes healthcare services affordable and accessible across all 50 states, and steps in to meet today’s immediate demands. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms: the Trxade B2B trading platform with 12,100 registered pharmacies, a licensed virtual wholesaler, affordable healthcare via its Bonum Health app or web-based telehealth services, and same-day or mail-order pharmacy-delivery capabilities via its DelivMeds app featuring its extensive nationwide distribution network. For additional information, please visit www.Trxade.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Software Development Among Key 3D Printing Industry Trends, Sigma Labs Inc. (NASDAQ: SGLB) Taking the Lead in Quality Control Solutions

• Software applications among key 3D printing growth trends for 2020
• SGLB’s PrintRite3D(R) software provides manufacturers with quality control solutions that can be remotely deployed throughout entire supply chain to any location worldwide
• Software solutions for 3D printing estimated at $1.4 billion, expected to exceed $3.9 billion by 2023

Despite the current global economic slowdown, the outlook for 3D printing remains optimistic, according to a recent article highlighting areas of growth for 2020 (http://ibn.fm/lLBgY). Most notably, trends like new product creation, increased aftermarket supply chains, and the race to create novel software applications that monitor quality control are predicted to take center stage. Sigma Labs Inc. (NASDAQ: SGLB), a leading provider of software solutions for the 3D metal printing industry, is positioned to benefit from growth in application development – a key trend – with its patented PrintRite3D(R) software that provides manufacturers with a consistent standard of quality assurance. Sigma Labs’ technology is capable of being remotely deployed throughout the entire supply chain to any location in the world.

Quality control solutions are vital for the industry to realize profits and achieve scale due to the high costs of rejected output and time spent in post-production inspections. With an estimated addressable market of $1.4 billion that is projected to exceed $3.9 billion by 2023, software development remains a key growth factor for the 3D metal printing industry. Accordingly, the venture capital market has shifted focus from hardware to application development, with over $1 billion raised by startups in 2019 and continued flows expected for 2020.

Despite the prevailing economic conditions, investment interest in 3D printing remains high. From its demonstrated flexibility in production, quickly providing medical supplies onsite to its ability to eliminate lengthy procurement processes or long shipping wait times, the technology offers critical solutions to longstanding industry woes (http://ibn.fm/znKmn).

Despite these benefits, quality control still continues to be a primary impediment to full industrialization due to a set of challenges that include a lack of product uniformity, profits lost due to rejected output, and costs associated with time spent in the post-production inspection phase. The 3D printing process creates objects by applying layers of raw material on top of each other, making in-process quality control measures absolutely critical for detecting anomalies in real time to allow for error correction. With its patented PrintRite3D(R) software, SGLB is an industry leader in the provision of quality control solutions that give operators the critical information required to observe the production process and address errors or anomalies taking place in real time. By enabling remote production from any location in the world, PrintRite3D(R) empowers operators to identify and fix machine inconsistencies during the printing process throughout the supply chain, so production can be optimized and modified in real time to produce higher quality yields, thus increasing profits.

PrintRite3D(R) runs on most major brands of 3D metal printers from different manufacturers, allowing for a standardized quality assurance process that can be deployed across the entire production chain. Created specifically for highly demanding precision-focused industries, PrintRite3D(R) is currently being evaluated by tier-1 manufacturers in the defense, aerospace, oil and gas, transportation and biomedical industries.

Founded by a team of Los Alamos National Labs scientists and engineers, Sigma Labs, Inc. originally developed and commercially licensed advanced metallurgical products prior to entering the additive manufacturing industry. As a leading provider of quality assurance software under the PrintRite3D(R) brand, SGLB’s stated objective is to become the de facto provider of quality assurance software to the 3D metal printing industry.

For more information about Sigma Labs, please visit www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces Strategic Engagements of Industry Experts to Advance Entry into U.S. Rare Earth Space

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading producer of uranium in the United States, today announced its entry into consulting agreements with Constantine Karayannopoulos and Brock O’Kelley, two rare earth element (“REE”) industry experts who each have decades of experience producing commercially viable rare earth products. According to the update, the collaborations will aid in the development and implementation of commercial and technical REE strategies for the new U.S. REE program Energy Fuels is pursuing. “Energy Fuels is extremely excited to bring Constantine Karayannopoulos and Brock O’Kelley on board to advance our entry into the rare earth space in the U.S.,” Mark S. Chalmers, President and CEO of Energy Fuels, said in the news release. “Over the past year or so, Energy Fuels has been actively evaluating this rare earth opportunity. We are quickly coming to the conclusion that the White Mesa Mill may be an ideal U.S. facility to process rare earth element ore streams and produce rare earth concentrates. Mr. Karayannopoulos and Mr. O’Kelley will assist Energy Fuels in the commercial and technical aspects of this endeavor. Mr. Karayannopoulos established Neo Material Technologies into a unique REE materials company, which is currently one of the World’s leading producers of REEs and a broad range of light and heavy rare earth engineered products outside of China. Neo was acquired for Cdn$1.3 billion in 2012 by Molycorp, the operator of the rare earth mine and processing facility in Mountain Pass, California. Neo maintained its cash flow and profitability, despite Molycorp’s 2015 reorganization. Mr. O’Kelley worked with Mr. Karayannopoulos at Molycorp as Technology Fellow and Vice President of Technology. He is currently an associate professor at the Colorado School of Mines working with REE related projects. Energy Fuels looks forward to working with these two industry veterans in developing our REE business in the U.S. and in advancing our relationships in this sector. Between Mr. Karayannopoulos, Mr. O’Kelley, and ANSTO of Sydney, Australia, we believe Energy Fuels is truly assembling a top flight team capable of building a successful U.S. REE business.”

To view the full press release, visit http://ibn.fm/IREKv

About Energy Fuels

Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant. Its corporate offices are in Lakewood, Colorado near Denver, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year, and has the ability to produce vanadium when market conditions warrant. The Nichols Ranch ISR Project is in operation and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is currently on standby. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html